IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.862
+0.024 (1.31%)
Oct 13, 2026, 12:39 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 276.9 million as of October 12, 2026. It is the 34,776th most valuable company in the world and the 468th biggest in Sweden. Its market cap has increased by 14.79% in one year.
Market Cap
276.90M
Enterprise Value
266.88M
Revenue
79.33M
Global Rank
Country Rank
#468 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 276.90M, a decrease of -32.95%. That is a compound annual growth rate of -4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 253.70M | 51.62% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 389.35M |
| Cantargia AB | 368.50M |
| Corline Biomedical AB | 359.33M |
| Mendus AB | 344.84M |
| Intervacc AB | 308.10M |
| Xbrane Biopharma AB | 260.66M |
| Isofol Medical AB | 252.87M |
| Elicera Therapeutics AB | 196.20M |